Company intelligence / Profile preview

GENETWORx

Glen Allen, Virginia, United States

Ownership: Private
Development stage: Other

Overview

GENETWORx is a national leader in molecular diagnostics, with clinical-grade services deployed across long-term care, state agencies, healthcare providers, and schools. It processed over 8 million COVID-19 tests with rapid turnaround and is CLIA certified and CAP accredited for high-complexity testing. GENETWORx technologies deliver actionable, patient-centered genetic insights for therapy selection and infectious disease management.

Therapeutic areas: OncologyInfectious DiseasesOther
Modalities: Molecular diagnosticsNext Generation Sequencing (NGS)DNA genotypingPharmacogenomic testing
Industry: Molecular Diagnostics

Partnerships

Collaborations with academic institutions, R&D laboratories, and healthcare providers (specific partners not disclosed)

Beyond the preview

Go deeper on GENETWORx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GENETWORx.

Explore the full profile